WCBA
CLX icon

Weaver C. Barksdale & Associates’s Clorox CLX Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,064
Closed -$840K – 549
2014
Q4 		$840K Buy
8,064
+450
+6% +$45K 0.68% 45
2014
Q3 		$731K Hold
7,614
– – 0.6% 65
2014
Q2 		$696K Hold
7,614
– – 0.56% 70
2014
Q1 		$670K Hold
7,614
– – 0.56% 69
2013
Q4 		$706K Buy
7,614
+3,885
+104% +$350K 0.59% 59
2013
Q3 		$305K Sell
3,729
-23,592
-86% -$1.99M 0.28% 90
2013
Q2 		$2.27M Buy
+27,321
New +$2.35M 2.24% 5

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AI
Analytic Investors Los Angeles, California $8.93B AUM 13.54% 1-Year Est. Return

Weaver C. Barksdale & Associates's CLX Position: Q1 2015 in Review

Weaver C. Barksdale & Associates sold out of Clorox (CLX) in Q1 2015, closing a stake of 8,064 shares — an estimated $840K sold.

Weaver C. Barksdale & Associates first reported a position in CLX in Q2 2013 and held it in 7 quarters. The position peaked at $2.27M in Q2 2013. 746 funds tracked by Wall St. Rank hold CLX as of Q1 2015.

  • Weaver C. Barksdale & Associates reported no remaining Clorox position as of Q1 2015 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 8,064 Clorox shares in Q1 2015, an estimated $840K.
  • Weaver C. Barksdale & Associates first reported a position in Clorox in Q2 2013 and held it in 7 quarters.
  • Weaver C. Barksdale & Associates's Clorox position peaked at $2.27M in Q2 2013.
  • 746 funds tracked by Wall St. Rank held Clorox as of Q1 2015.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2015, filed 9 Apr 2015.